Literature DB >> 3262116

Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine, and uric acid release from the hypoxemic rat cerebral cortex.

J W Phillis1, M H O'Regan, G A Walter.   

Abstract

The effects of the adenosine deaminase inhibitor, deoxycoformycin, on purine release from the rat cerebral cortex were studied with the cortical cup technique. Deoxycoformycin (5 and 500 micrograms/kg i.v.) enhanced the hypoxia/ischemia-evoked release of adenosine from the cerebral cortex, indicating a marked rise in the adenosine content of interstitial fluid in the cerebral cortex. Inosine and hypoxanthine release were attenuated at the higher dose of deoxycoformycin. Uric acid release into the cortical perfusates was enhanced at the higher dose level. These results demonstrate that low doses of deoxycoformycin can be used to elevate interstitial levels of adenosine in the brain during hypoxia, and to depress the formation of some of its metabolites. The elevation of hypoxia/ischemia-evoked adenosine levels can account for the previously reported potentiation of hypoxia-evoked increases in rat cerebral blood flow after deoxycoformycin administration. The potential therapeutic utility of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262116     DOI: 10.1038/jcbfm.1988.121

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

1.  The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kelly Greene; Yongjiao Zhai; Edward P Amento
Journal:  Cell Signal       Date:  2016-02-19       Impact factor: 4.315

2.  Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kaviya S Raveendran; Edward P Amento
Journal:  Cell Signal       Date:  2017-11-08       Impact factor: 4.315

3.  Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo.

Authors:  Y Chen; D I Graham; T W Stone
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

4.  Moderate hypoxia reduces pentylenetetrazol-induced seizures.

Authors:  C Rauca; H L Rüthrich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

5.  A model for adenosine transport and metabolism.

Authors:  J J Centelles; M Cascante; E I Canela; R Franco
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

Review 6.  Adenosine: a prototherapeutic concept in neurodegeneration.

Authors:  D K von Lubitz; M F Carter; M Beenhakker; R C Lin; K A Jacobson
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

7.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

8.  Specialist and Generalist Fungal Parasites Induce Distinct Biochemical Changes in the Mandible Muscles of Their Host.

Authors:  Shanshan Zheng; Raquel Loreto; Philip Smith; Andrew Patterson; David Hughes; Liande Wang
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.